1. Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity;Tortora;Clin Cancer Res,2001
2. Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839;Albanell;Semin Oncol,2001
3. Clinical advancement of EGFR inhibitors in cancer therapy;Chinnaiyan;Methods Mol Biol,2006
4. Cetuximab for treatment of metastatic colorectal cancer;Cerea;Ann Oncol,2006
5. Targeting the epidermal growth factor receptor. Trials in head and neck and lung cancer;Saba;Oncology (Williston Park),2006